ZW25 (Zanidatamab)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ZW25 (Zanidatamab), covering 2025-05-25 to 2025-09-12. Get the full timeline:
Most recent: Clinical Trial Update: A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer [Phase 2]